| UDI-DI | EVIRUVCGKI1 |
|---|---|
| Secondary DI | |
| Nr katalogowy | V-UVCGKI |
| Status rynkowy | Na rynku UE |
| Pierwsze wprowadzenie | Niemcy |
| Wersja EUDAMED | 1 |
| Rodzaj (EMDN) | REAGENTS › INFECTIOUS DISEASES › OTHER INFECTIOUS IMMUNOLOGY/NAT › OTHER INFECTIOUS IMMUNOLOGY REAGENTS › BUFFERS (UNASSIGNABLE ), SUPPLEM. REAGENTS, ETC |
| Kody EMDN | W0105900201 BUFFERS (UNASSIGNABLE ), SUPPLEM. REAGENTS, ETC |
ViraChip® AP-Anti-Human IgG Conjugate
Viramed Biotech AG · DE-MF-000020368
| Basic UDI-DI | ++EVIRConjugate5E |
|---|---|
| Nazwa wyrobu | Conjugate |
| Model | |
| Klasa ryzyka | Klasa A |
| Podstawa prawna | IVDR |
| Typ | odczynnik |
| Użytek profesjonalny | tak |
Brak Danych dodatkowych – dane z backendu interfejsu EUDAMED nie zostały jeszcze pobrane.
Inne Warianty tego Wyrobu
- EVIRUVCMKI1 ViraChip® AP-Anti-Human IgM Conjugate V-UVCMKI
- EVIRUVCAKI1 ViraChip® AP-Anti-Human IgA Conjugate V-UVCAKI
- EVIRUVNGKI1 ViraStripe® / ViraBlot AP-Anti-Human IgG Conjugate V-UVNGKI
- EVIRUVNMKI151 ViraChip® AP-Anti-Human IgM Conjugate V-UVNMKI15
- EVIRUVNAKI1 ViraStripe® / ViraBlot AP-Anti-Human IgA Conjugate V-UVNAKI
- EVIRUVNAKI151 ViraChip® AP-Anti-Human IgA Conjugate V-UVNAKI15
- EVIRUVNAKI451 ViraStripe® / ViraBlot AP-Anti-Human IgA Conjugate V-UVNAKI45
- EVIRUVNGKI451 ViraStripe® / ViraBlot AP-Anti-Human IgG Conjugate V-UVNGKI45
- EVIRUVNMKI451 ViraStripe® / ViraBlot AP-Anti-Human IgM Conjugate V-UVNMKI45
- EVIRUVCGKI121 ViraChip® AP-Anti-Human IgG Conjugate V-UVCGKI12
- EVIRUVNGKI151 ViraChip® AP-Anti-Human IgG Conjugate V-UVNGKI15
- EVIRUVNMKI1 ViraStripe® / ViraBlot AP-Anti-Human IgM Conjugate V-UVNMKI